CLEXM has demonstrated that cryo-SXT can be integrated with fluorescence and electron microscopy to produce 3D, multiscale views of biological systems. This strengthens Europe’s leadership in correlative imaging, a rapidly expanding field that is attracting international interest. The workflows enable high-resolution imaging of cells in their near-native state, revealing new insights into processes such as West Nile virus infection and nanoparticle trafficking, while also providing structural context in more complex models, including cochlear tissue and cilia in C. elegans.
For broader uptake, several needs have been identified. Cryo-sample preparation remains a global challenge across imaging communities; minor inconsistencies can compromise entire experiments. By refining reproducible protocols, CLEXM directly contributes to overcoming this barrier, benefiting both the consortium and the wider structural biology field. Further investment in automation and AI-driven analysis is required to accelerate data interpretation. The SXT100, as the first of its kind benchtop soft X-ray microscope, complements synchrotron and cryoEM facilities by providing additional capacity and flexibility, helping to alleviate scheduling pressure and ensuring more equitable access to cryo-SXT within the consortium and beyond.
With these measures in place, CLEXM will continue to bridge scientific innovation, supporting applications in pharma, nanomedicine, and structural biology.